The University of Texas Health Science at Houston (UTHealth) has elected Lorraine Frazier, Ph.D., R.N., F.A.A.N. the new dean of its School of Nursing. Having served as a member of the UTHealth School of Nursing since 1997, Frazier is succeeding former dean Patricia Starck, Ph.D., R.N., F.A.A.N., and will begin her new role on February 2. Starck had previously announced her retirement for February after serving the school for 30 years, and will continue her functions as UTHealth’s senior vice president for Interprofessional Education.
Frazier’s journey with the UTHealth School of Nursing began during her nursing education, receiving both her M.S.N. and doctorate at the school. In 1997, Frazier started working there as research assistant, and five years later was recognized with the distinguished alumna award. Between 2008 and 2011, she was the Nancy B. Willerson Distinguished Professor in Nursing, assistant dean and Nursing Systems department chair, and between 2009 and 2012, a Robert Wood Johnson Executive Nurse Program Fellow.
“We are excited that Dr. Frazier is returning to UTHealth to lead our outstanding and nationally-recognized nursing school,” said the president of UTHealth, Giuseppe N. Colasurdo, M.D., in a press release. “I am confident that Dr. Frazier will further the school’s legacy of service to its students, faculty and community.”
In addition, Frazier has also studied genetics and hypertension at the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM) at UTHealth, earned an M.S. in clinical research from the UTHealth Medical School, a B.S.N. from the University of Oklahoma, and a A.D.N. from Southwest Texas State University.
“It is an honor and a privilege to come back to Houston and UTHealth. The school is my alma mater and I am excited to serve with the faculty and move the school forward,” Frazier said. “My objectives are to take the school forward in both education and research. I want to focus on building the research agenda and the interprofessional collaboration. This is a fantastic opportunity to build on the solid foundation left by Dean Starck.”
Her work is widely recognized and, in 2006, Frazier was named director of the Clinical and Translational Science Awards (CTSA) Biobank Consortium, and her research has been granted more than $4 million in funding and $2.8 million in program grants. Frazier has been dedicated to the study of biomarkers for depression, as well as the correlation between mental health and the development of cardiovascular diseases.